Views & Analysis | Perspectives on pharma industry issues

Sales & Marketing

Pharma’s search loophole is a preview of what comes next

PPC ads often contain so little text that they avoid direct claims. Many consist only of a brand name, a link, and limited copy.

Digital

Sponsored

Legacy data into living scientific memory

The pharmaceutical industry is racing to turn its data into scientific intelligence with AI. Now it’s possible to connect your data and tool ecosystem

R&D

Clinical trials, various research areas, concept

Clinical Trials Round-Up – Jan to Feb 2026

Read how Jan-Feb '26 offered a revealing cross-section of how R&D is evolving across therapy areas.

R&D

pharmaphorum podcast Episode 248, Andrew McKinnon, Medable

AI in clinical development & ‘white space’, with Andrew McKi...

Andrew McKinnon, senior vice president and executive general manager at Medable, discussesleveraging AI to transform & accelerate clinical development

Digital

Sponsored

Accelerating the content lifecycle: A 7-step guide for AI in...

By integrating AI agents into medical, legal, and regulatory (MLR) processes, organisations can transform content lifecycle management.

Market Access

This is what’s keeping pharmaceutical CISOs up at night

The role of CISO in the pharmaceutical industry is a position that comes with a great deal of responsibility, but designing and implementing a strategy that checks all the boxes is a tall ask

R&D

Bayer’s bet on CGT: Casting a wide net for innovation

With the opening of Co.Labs, Bayer's flagship coworking space for biotech start-ups in CGT, the company looks to cast a wide net for external and internal innovation in the emerging space.

Sales & Marketing

Eight components of effective brand planning tools

Daniel Kohlstaedt, managing director and founder of PurpleLeaf Strategy, outlines the key elements brand planning platform technology must have to help brand teams optimise their strategies.

Sales & Marketing

Pharma’s search loophole is a preview of what comes next

PPC ads often contain so little text that they avoid direct claims. Many consist only of a brand name, a link, and limited copy.

Sales & Marketing

virtual electronic medical record interface

Sponsored

5 forces reshaping pharma commercialisation in 2026

As infrastructure bottlenecks ease and regulatory frameworks mature, pharma's AI adoption is shifting from proof-of-concept to production-grade deployment

Digital

Sponsored

Legacy data into living scientific memory

The pharmaceutical industry is racing to turn its data into scientific intelligence with AI. Now it’s possible to connect your data and tool ecosystem

Digital

Sponsored

Accelerating the content lifecycle: A 7-step guide for AI in...

By integrating AI agents into medical, legal, and regulatory (MLR) processes, organisations can transform content lifecycle management.

Market Access

What rare disease commercialisation in Europe teaches us - a...

Rare disease launches are the ultimate stress test for European commercialisation.

Market Access

Biotech leaders: ‘They're shoving this industry into the arm...

At the Biotech Showcase during JPM Week, biotech leaders expressed frustration at the US's lack of concern about Chinese biotech progress.

Oncology

Sponsored

Collaboration & personalisation in rare disease R&D, with AO...

For Rare Disease Day, in an AOP Health-sponsored podcast Melissa Fellner, VP of Global Therapeutic Areas, Commercial Operations, discussed their work.

Oncology